S. Matsuoka
发表
S. Fujiwara,
Kazuya Sato,
M. Ashizawa,
2021,
Internal medicine.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2022,
Leukemia & lymphoma.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2021,
Leukemia research.
Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation.
S. Fujiwara,
Kazuya Sato,
M. Ashizawa,
2022,
Leukemia research.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2020,
Annals of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2022,
Internal medicine.
Daratumumab in first-line is cost-effective in transplant-eligible newly diagnosed myeloma patients.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2022,
Blood.